ClinicalTrials.gg
RecruitingNCT04787874Updated Dec 15, 2021

Effect of Prehabilitation on Surgical Outcomes of Abdominally-based Plastic Surgery Procedures

An interventional study of Prehabilitation Program in Ventral Hernia, Panniculus and Abdominoplasty, sponsored by Stanford University. Recruiting at 2 sites in United States. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-12-15.

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started Jun 2021; still recruiting 5 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
520
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine whether a program to optimize patient physical fitness and nutrition ("prehabilitation") prior to and after plastic surgery involving the abdomen improves surgical outcomes. The investigators hope to determine how a multimodal peri-operative prehabilitation program can be most effective in engaging and motivating patients to physically and mentally get ready for an abdominally-based plastic surgery operation. The overall goal is to determine if this program will improve post-operative recovery after abdominally-based plastic surgery. The importance of this new knowledge is better understanding of ways that plastic surgeons can improve outcomes, engagement, and experience of patients undergoing abdominally-based plastic surgery operations. This would translate to increased healthcare value and better long-term outcomes.

02

Conditions studied

  • Ventral Hernia
  • Panniculus
  • Abdominoplasty
  • Flap Reconstruction

Browse trials for

03

In context

Hernia, Ventral

230 studies on the registry are indexed under Hernia, Ventral; 45 are open to participants now.

This study's planned enrollment of 520 is above the median of 90 across 153 interventional studies indexed under Hernia, Ventral.

Browse Hernia, Ventral studies →

Lead sponsor

Stanford University is the lead sponsor of 2,168 studies on the registry; 431 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (>18 years) who are undergoing elective abdominally-based plastic surgery operations in 3+ weeks by one of the following plastic surgeons: Nazerali, Lee, Murphy, Nguyen, Lorenz.

Exclusion criteria

Exclusion Criteria:

  • Patients who do not speak English
  • Patients who do not have access to a smartphone or internet/cell service.
  • Patients who are undergoing another intervention study that consists of a nutrition and/or exercise behavior change.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
520 participants (estimated)

Study arms

  • No intervention
    Control

    The control arm will receive no additional prehabilitation material prior to material. Rather, they will receive standard preoperative care in which they will be given standard advice on nutrition and fitness. REDcap surveys will be administered.

  • Experimental
    Prehab Intervention Arm

    The intervention arm will receive access to the prehab program (abdominal workout videos) and surveys via RedCAP.The program will start no less than 14 days before the date of surgery.

    Behavioral: Prehabilitation Program

Interventions

  • BehavioralPrehabilitation Program

    Nutrition component: Participants will receive information on how to follow a healthy diet (Mediterranean-style diet) with emphasis on whole foods, plants, lean protein, olive oil; restriction of red meats, processed meats, processed foods, added sugar) Exercise component: Participants will receive an activity tracker to use during the study period (3+ weeks before surgery, and 30 days after surgery). Participants will be assigned strength exercises to work on core strength and proximal muscle strength (biceps/triceps, quads, hamstrings, calves).The exercises will mainly be focused on strengthening the abdominal wall. Exercises will be tailored to patients' individual capabilities. They will also be assigned cardio exercises - either low-intensity steady state cardio vs High Intensity Interval training. Level of cardio exercise will be tailored based on patient's Duke Activity score and baseline activity.

06

What researchers measure

Primary outcomes

  1. Occurrence of surgical complications (Post-op days 7-14)

    Will analyze the occurrence of surgical complications after surgery. Hematoma, seroma, or abscess.

    Time frame: Post-operative days 7-14

  2. Occurrence of surgical complications (Post-op day 30)

    Will analyze the occurrence of surgical complications after surgery. Hematoma, seroma, or abscess.

    Time frame: Post-operative day 30

  3. Occurrence of surgical complications (Post-op day 90)

    Will analyze the occurrence of surgical complications after surgery. Hematoma, seroma, or abscess.

    Time frame: Post-operative day 90

  4. Occurrence of surgical complications (Post-op day 180)

    Will analyze the occurrence of surgical complications after surgery. Hematoma, seroma, or abscess.

    Time frame: Post-operative day 180

  5. Occurrence of surgical complications (Post-op day 360)

    Will analyze the occurrence of surgical complications after surgery. Hematoma, seroma, or abscess.

    Time frame: Post-operative day 360

  6. Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op days 7-14

    Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure. The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.

    Time frame: Post-operative days 7-14

  7. Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op days 7-14

    Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure. The ASIS score ranges from 18-126, having higher scores indicate better quality of life.

    Time frame: Post-operative days 7-14

  8. Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op day 30

    Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure. The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.

    Time frame: Post-operative day 30

  9. Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op day 30

    Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure. The ASIS score ranges from 18-126, having higher scores indicate better quality of life.

    Time frame: Post-operative day 30

  10. Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op day 90

    Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure. The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.

    Time frame: Post-operative day 90

  11. Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op day 90

    Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure. The ASIS score ranges from 18-126, having higher scores indicate better quality of life.

    Time frame: Post-operative day 90

  12. Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op day 180

    Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure. The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.

    Time frame: Post-operative day 180

  13. Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op day 180

    Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure. The ASIS score ranges from 18-126, having higher scores indicate better quality of life.

    Time frame: Post-operative day 180

  14. Patient-Reported Outcome Measures: RAND 36-Item Health Survey (RAND-36) on Post-op day 360

    Will use the RAND 36-Item Health Survey (RAND-36) to assess the patient's perceived health following their surgical procedure. The score for RAND-36 ranges from 0-100, having higher scores mean better outcomes.

    Time frame: Post-operative day 360

  15. Patient-Reported Outcome Measures: Abdominal Surgery Impact Scale (ASIS) on Post-op day 360

    Will use the Abdominal Surgery Impact Scale (ASIS) to assess the patient's perceived health following their surgical procedure. The ASIS score ranges from 18-126, having higher scores indicate better quality of life.

    Time frame: Post-operative day 360

  16. Physical Function Test: 6-minute walk test at Time of Enrollment

    Will use the 6-minute walk test. The 6-minute walk test will be used to assess aerobic capacity and endurance. A normal walk distance ranges from 400 to 700 m.

    Time frame: Time of enrollment

  17. Physical Function Test: 5-times-sit-to-stand test at Time of Enrollment

    Will use the 5-times-sit-to-stand test. The 5-times-sit-to-stand test is a method to quantify functional lower extremity strength. Lower times indicate better scores.

    Time frame: Time of enrollment

  18. Physical Function Test: Timed-up-and-go test at Time of Enrollment

    Will use the timed-up-and-go test. The timed-up-and go test assesses one's mobility. A lower score signifies better mobility.

    Time frame: Time of enrollment

  19. Physical Function Test: 6-minute walk test at 3 weeks

    Will use the 6-minute walk test. The 6-minute walk test will be used to assess aerobic capacity and endurance. A normal walk distance ranges from 400 to 700 m.

    Time frame: 3 weeks

  20. Physical Function Test: 5-times-sit-to-stand test at 3 weeks

    Will use the 5-times-sit-to-stand test. The 5-times-sit-to-stand test is a method to quantify functional lower extremity strength. Lower times indicate better scores.

    Time frame: 3 weeks

  21. Physical Function Test: Timed-up-and-go test at 3 weeks

    Will use the timed-up-and-go test. The timed-up-and go test assesses one's mobility. A lower score signifies better mobility.

    Time frame: 3 weeks

  22. Physical Function Test: 6-minute walk test on Post-op Day 30

    Will use the 6-minute walk test. The 6-minute walk test will be used to assess aerobic capacity and endurance. A normal walk distance ranges from 400 to 700 m.

    Time frame: Post-operative day 30

  23. Physical Function Test: 5-times-sit-to-stand-test on Post-op Day 30

    Will use the 5-times-sit-to-stand test. The 5-times-sit-to-stand test is a method to quantify functional lower extremity strength. Lower times indicate better scores.

    Time frame: Post-operative day 30

  24. Physical Function Test: Timed-up-and-go test on Post-op Day 30

    Will use the timed-up-and-go test. The timed-up-and go test assesses one's mobility. A lower score signifies better mobility.

    Time frame: Post-operative day 30

  25. Physical Function Test: 6-minute walk test on Post-op Day 90

    Will use the 6-minute walk test. The 6-minute walk test will be used to assess aerobic capacity and endurance. A normal walk distance ranges from 400 to 700 m.

    Time frame: Post-operative day 90

  26. Physical Function Test: 5-times-sit-to-stand test on Post-op Day 90

    Will use the 5-times-sit-to-stand test. The 5-times-sit-to-stand test is a method to quantify functional lower extremity strength. Lower times indicate better scores.

    Time frame: Post-operative day 90

  27. Physical Function Test: Timed-up-and-go test on Post-op Day 90

    Will use the timed-up-and-go test. The timed-up-and go test assesses one's mobility. A lower score signifies better mobility.

    Time frame: Post-operative day 90

Secondary outcomes

  1. Change from Baseline Albumin Levels at Time of Surgery

    To analyze nutritional status

    Time frame: Enrollment to time of surgery

  2. Change from Baseline Prealbumin Levels at Time of Surgery

    To analyze nutritional status

    Time frame: Enrollment to time of surgery

  3. Change from Baseline Transferrin Levels at Time of Surgery

    To analyze nutritional status

    Time frame: Enrollment to time of surgery

  4. Change from Baseline C-reactive Protein Levels at Time of Surgery

    To analyze level of physiologic inflammation

    Time frame: Enrollment to time of surgery

  5. Change from Baseline Erythrocyte Sedimentation Rates at Time of Surgery

    To analyze level of physiologic inflammation

    Time frame: Enrollment to time of surgery

  6. Change from Baseline Hemoglobin A1C Levels at Time of Surgery

    To analyze degree of diabetes mellitus control

    Time frame: Enrollment to time of surgery

  7. Change from Baseline Plasma Glucose Levels at Time of Surgery

    To analyze degree of diabetes mellitus control

    Time frame: Enrollment to time of surgery

  8. Change from Baseline White Blood Cell Count at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of the complete blood count.

    Time frame: Enrollment to time of surgery

  9. Change from Baseline Hemoglobin Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of the complete blood count.

    Time frame: Enrollment to time of surgery

  10. Change from Baseline Hematocrit Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of the complete blood count.

    Time frame: Enrollment to time of surgery

  11. Change from Baseline Platelet Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of the complete blood count.

    Time frame: Enrollment to time of surgery

  12. Change from Baseline Chloride Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel

    Time frame: Enrollment to time of surgery

  13. Change from Baseline Sodium Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel

    Time frame: Enrollment to time of surgery

  14. Change from Baseline Potassium Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel

    Time frame: Enrollment to time of surgery

  15. Change from Baseline Carbon Dioxide Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel

    Time frame: Enrollment to time of surgery

  16. Change from Baseline Blood Urea Nitrogen Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel

    Time frame: Enrollment to time of surgery

  17. Change from Baseline Creatinine Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel

    Time frame: Enrollment to time of surgery

  18. Change from Baseline Blood Glucose Levels at Time of Surgery

    Assessment for leukocytosis, anemia, renal disease; Part of Basic Metabolic Panel

    Time frame: Enrollment to time of surgery

07

Study locations

2 of 2 sites recruiting
  • Stanford Cancer Center South Bay
    San Jose, California 95124, United States
    Recruiting
    • Rahim Nazerali, MD, MHS · Contact
  • Stanford Plastic and Reconstructive Surgery Clinic
    Stanford, California 94304, United States
    Recruiting
    • Rahim Nazerali, MD, MHS · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04787874
Responsible party
Cara Black (Resident Physician, PGY-1, Stanford University) — Principal investigator
First posted
Mar 9, 2021
Start date
Jun 21, 2021
Primary completion
May 23, 2025 (estimated)
Completion
Jun 2, 2025 (estimated)
Last update
Dec 15, 2021

Study contacts

Cara Black, PGY-2
Contact
carablack@stanford.edu
650-723-7001
Cindy Kin, MD
study director · Asst Prof-Med Ctr Line
Cara Black, MD
principal investigator · Resident

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion